Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18015
Abstract: Secukinumab is administered at the labelled dose of 300 mg at weeks 0, 1, 2, 3, 4 (loading dose) and every 4 weeks thereafter. read more here.
Keywords: efficacy secukinumab; initial weekly; without initial; secukinumab ... See more keywords